Cartesian Therapeutics Inc (RNAC)
19.12
-0.56
(-2.85%)
USD |
NASDAQ |
Nov 04, 16:00
19.12
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Total Assets (Quarterly): 347.74M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 347.74M |
| March 31, 2024 | 325.21M |
| December 31, 2023 | 305.05M |
| September 30, 2023 | 106.03M |
| June 30, 2023 | 139.51M |
| March 31, 2023 | 155.69M |
| December 31, 2022 | 165.89M |
| September 30, 2022 | 178.26M |
| June 30, 2022 | 188.07M |
| March 31, 2022 | 145.70M |
| December 31, 2021 | 159.88M |
| September 30, 2021 | 167.16M |
| June 30, 2021 | 180.52M |
| March 31, 2021 | 176.75M |
| December 31, 2020 | 165.44M |
| September 30, 2020 | 181.00M |
| June 30, 2020 | 75.21M |
| March 31, 2020 | 88.80M |
| Date | Value |
|---|---|
| December 31, 2019 | 99.57M |
| September 30, 2019 | 39.54M |
| June 30, 2019 | 46.95M |
| March 31, 2019 | 62.48M |
| December 31, 2018 | 44.48M |
| September 30, 2018 | 60.32M |
| June 30, 2018 | 73.44M |
| March 31, 2018 | 89.94M |
| December 31, 2017 | 101.10M |
| September 30, 2017 | 109.72M |
| June 30, 2017 | 117.02M |
| March 31, 2017 | 73.86M |
| December 31, 2016 | 89.30M |
| September 30, 2016 | 85.78M |
| June 30, 2016 | 91.32M |
| March 31, 2016 | 34.72M |
| December 31, 2015 | 42.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
75.21M
Minimum
Jun 2020
347.74M
Maximum
Jun 2024
176.39M
Average
165.89M
Median
Dec 2022
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | 4.205B |
| Amgen Inc | 90.88B |
| Johnson & Johnson | 178.29B |
| Regeneron Pharmaceuticals Inc | 37.44B |
| NovaBay Pharmaceuticals Inc | 3.925M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 449.20M |
| Shareholders Equity (Quarterly) | -101.46M |
| Current Ratio | 4.778 |
| Net Debt Paydown Yield | 1.10% |